Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberley S Mak

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Thoracic Disease|July 19, 2021
Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative reviewYue Lin, Kimberley S Mak
Journal of the National Cancer Institute. Monographs|June 12, 2015
Radiotherapy Issues After Neoadjuvant ChemotherapyKimberley S Mak, Jay R Harris
Cancer Medicine|April 26, 2017
Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer DatabaseKimberley S Mak, Ankit Agarwal, Muhammad M Qureshi, et al.
Pediatric Blood & Cancer|August 31, 2017
Clinical outcomes and toxicity following palliative radiotherapy for childhood cancersKimberley S Mak, Stephanie W Lee, Tracy A Balboni, et al.
Advances in Radiation Oncology|November 11, 2024
Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung CancerYue Lin, Muhammad M Qureshi, Sonny Batra, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality TherapyLeslie K Ballas, Andrzej Niemierko, Kimberley S Mak, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancerSherry X Yan, Muhammad M Qureshi, Michael Dyer, et al.
Journal of Racial and Ethnic Health Disparities|November 28, 2022
Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net HospitalAnqi Liu, Noreen Siddiqi, Umit Tapan, et al.
JTO Clinical and Research Reports|September 30, 2021
Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLCUmit Tapan, Vanessa Fiorini Furtado, Muhammad Mustafa Qureshi, et al.
Journal of Thoracic Disease|September 8, 2022
Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survivalMichelle H Lee, Muhammad Mustafa Qureshi, Kei Suzuki, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Thoracic Disease|July 19, 2021
Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative reviewYue Lin, Kimberley S Mak
Journal of the National Cancer Institute. Monographs|June 12, 2015
Radiotherapy Issues After Neoadjuvant ChemotherapyKimberley S Mak, Jay R Harris
Cancer Medicine|April 26, 2017
Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer DatabaseKimberley S Mak, Ankit Agarwal, Muhammad M Qureshi, et al.
Pediatric Blood & Cancer|August 31, 2017
Clinical outcomes and toxicity following palliative radiotherapy for childhood cancersKimberley S Mak, Stephanie W Lee, Tracy A Balboni, et al.
Advances in Radiation Oncology|November 11, 2024
Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung CancerYue Lin, Muhammad M Qureshi, Sonny Batra, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality TherapyLeslie K Ballas, Andrzej Niemierko, Kimberley S Mak, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancerSherry X Yan, Muhammad M Qureshi, Michael Dyer, et al.
Journal of Racial and Ethnic Health Disparities|November 28, 2022
Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net HospitalAnqi Liu, Noreen Siddiqi, Umit Tapan, et al.
JTO Clinical and Research Reports|September 30, 2021
Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLCUmit Tapan, Vanessa Fiorini Furtado, Muhammad Mustafa Qureshi, et al.
Journal of Thoracic Disease|September 8, 2022
Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survivalMichelle H Lee, Muhammad Mustafa Qureshi, Kei Suzuki, et al.
Pageof 5